SCHEMBL31400522

SCHEMBL31400522

Cc1ccc(C(=O)NCc2cc3nc(N4CCC(c5cccnc5)C4)ccc3cn2)cc1S(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.42
▸ KCNJ1 P48048 1/20 0.39
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ USP5 P45974 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ NAMPT P43490 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ THRA P10827 1/20 0.34
▸ VDR P11473 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31400908 1.00 PDE10A (0.42) PDE10AKCNJ1KMT2AMEN1LMNA
SCHEMBL31400884 1.00 PDE10A (0.42) PDE10AKCNJ1KMT2AMEN1LMNA
SCHEMBL31400594 0.96 PDE10A (0.38) PDE10AKCNJ1KMT2AMEN1LMNA
SCHEMBL31400488 0.96 PDE10A (0.38) PDE10AKCNJ1KMT2AMEN1LMNA
SCHEMBL31400464 0.96 PDE10A (0.38) PDE10AKCNJ1KMT2AMEN1LMNA
SCHEMBL31400796 0.96 KCNJ1 (0.40) PDE10AKCNJ1KMT2AMEN1LMNA
SCHEMBL31400776 0.92 MEN1 (0.41) PDE10AKMT2AMEN1SMN1; SMN2RAB9A
SCHEMBL31400941 0.92 MEN1 (0.41) PDE10AKMT2AMEN1SMN1; SMN2RAB9A
SCHEMBL31400633 0.88 KMT2A (0.40) PDE10AKMT2AMEN1SMN1; SMN2RAB9A
SCHEMBL31400535 0.88 KMT2A (0.40) PDE10AKMT2AMEN1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 — — EP claimed
WO-2025008058-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS JANSSEN PHARMACEUTICA NV (BE) 2025-01-09 — — WO claimed
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 — — EP disclosed
WO-2025008058-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS JANSSEN PHARMACEUTICA NV (BE) 2025-01-09 — — WO disclosed
Send feedback